SAI
ORMP icon

Savvy Advisors Inc’s Oramed Pharmaceuticals ORMP Stock Holding History

Savvy Advisors Inc’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,810
Closed -$45.9K – 475
2024
Q3 		$45.9K Hold
18,810
– – 0.01% 346
2024
Q2 		$48.3K Hold
18,810
– – 0.02% 295
2024
Q1 		$54.9K Buy
+18,810
New +$52.6K 0.03% 215

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Savvy Advisors Inc's ORMP Position: Q4 2024 in Review

Savvy Advisors Inc sold out of Oramed Pharmaceuticals (ORMP) in Q4 2024, closing a stake of 18,810 shares — an estimated $45.9K sold.

Savvy Advisors Inc first reported a position in ORMP in Q1 2024 and held it in 3 quarters. The position peaked at $54.9K in Q1 2024. 56 funds tracked by Wall St. Rank hold ORMP as of Q4 2024.

  • Savvy Advisors Inc reported no remaining Oramed Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Savvy Advisors Inc sold 18,810 Oramed Pharmaceuticals shares in Q4 2024, an estimated $45.9K.
  • Savvy Advisors Inc first reported a position in Oramed Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Savvy Advisors Inc's Oramed Pharmaceuticals position peaked at $54.9K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q4 2024.

Based on Savvy Advisors Inc's 13F filing for Q4 2024, filed 13 Feb 2025.